1. 1) Doble A. The role of excitotoxicity in neurodegenerative disease: implications for therapy. Pharmacol. Ther., 81, 163–221 (1999).
2. 2) Meldrum BS. Glutamate as a neurotransmitter in the brain: review of physiology and pathology. J. Nutr., 130 (Suppl.), 1007S–1015S (2000).
3. 3) Supnet C, Bezprozvanny I. The dysregulation of intracellular calcium in Alzheimer’s disease. Cell Calcium, 47, 183–189 (2010).
4. 4) Martin LJ, Al-Abdulla NA, Brambrink AM, Kirsch JR, Sieber FE, Portera-Cailliau C. Neurodegeneration in excitotoxicity, global cerebral ischemia, and target deprivation: a perspective on the contributions of apoptosis and necrosis. Brain Res. Bull., 46, 281–309 (1998).
5. 5) Dong XX, Wang Y, Qin ZH. Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases. Acta Pharmacol. Sin., 30, 379–387 (2009).